Stephan R. Targan
Director/Board Member at Alimentiv, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rolf Classon | M | 79 |
Prometheus RxDx, Inc.
 Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | 15 years |
| Robert S. Whitehead | M | 74 |
Prometheus RxDx, Inc.
Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | 15 years |
| Timothy Sear | M | 86 |
Prometheus RxDx, Inc.
Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | 15 years |
| F. Mills | M | 72 |
Alimentiv, Inc.
 Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | 9 years |
| Michael S. Cloutier | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Cecil Shewchuk | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Jürgen Schölmerich | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Paul Knill | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Lisa Harrison | F | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | 11 years |
| Ross Feldman | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Jennifer Roedding | F | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
| Pierre Gaudreault | M | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Justin M. Sobaje | M | - |
University of California, Los Angeles
| 9 years |
| William Franzblau | M | 61 |
Prometheus RxDx, Inc.
Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | - |
| John W. Kittrell | M | - |
University of California, Los Angeles
| 5 years |
| Paul B. Thomas | M | - |
University of California, Los Angeles
| 11 years |
| Scott A. Henry | M | - |
University of California, Los Angeles
| 2 years |
| Angela Colt | F | - |
University of California, Los Angeles
| 5 years |
| Julie E. Croner | F | - |
University of California, Los Angeles
| 7 years |
| Patrick H. Hu | M | - |
University of California, Los Angeles
| 7 years |
| Nima Khajehnouri | M | - |
University of California, Los Angeles
| 4 years |
| Kent Douglas Daniel | M | - |
University of California, Los Angeles
| 6 years |
| Marshall Davert | M | - |
University of California, Los Angeles
| 3 years |
| John R. Watters | M | - |
University of California, Los Angeles
| 3 years |
| Paul R. Daza | M | 62 |
University of California, Los Angeles
| 7 years |
| Lan T. Tran | F | 48 |
University of California, Los Angeles
| 6 years |
| Steven L. Canepa | M | - |
University of California, Los Angeles
| 7 years |
| Patrick W. Dennis | M | - |
University of California, Los Angeles
| 3 years |
| Stephen D. Cooke | M | - |
University of California, Los Angeles
| 3 years |
| Wing Cheung Hwang | M | 48 |
University of California, Los Angeles
| 6 years |
| Thomas T. Marshall | M | - |
University of California, Los Angeles
| 6 years |
| Edward Fan | M | - |
University of California, Los Angeles
| 5 years |
| Muhammad Sirajuddin Syamsuddin | M | 64 |
University of California, Los Angeles
| 4 years |
| George Akopov | M | - |
University of California, Los Angeles
| 7 years |
| Karen Malmuth Kaufmann | M | - |
University of California, Los Angeles
| 5 years |
| Jesse Draper | F | - |
University of California, Los Angeles
| 4 years |
| Yu Hin Wang | M | 38 |
University of California, Los Angeles
| 8 years |
| Ernesto Cervera | M | 66 |
University of California, Los Angeles
| 2 years |
| Stephanie Bontemps | F | - |
University of California, Los Angeles
| 7 years |
| Geng Xiao | M | 61 |
University of California, Los Angeles
| 5 years |
| Kevin Andrew Frankel | M | - |
University of California, Los Angeles
| 7 years |
| Hiep Nguyen | M | - |
University of California, Los Angeles
| 5 years |
| Mark L. Levin | M | - |
University of California, Los Angeles
| 7 years |
| Montague Yort | M | 60 |
University of California, Los Angeles
| 10 years |
| Dan Beaney | M | - |
University of California, Los Angeles
| 5 years |
| Michael M. Kagawa | M | - |
University of California, Los Angeles
| 18 years |
| Elemer Piros | M | - |
University of California, Los Angeles
| 8 years |
| Winn Hong | M | 54 |
University of California, Los Angeles
| 6 years |
| Glen Y. Sato | M | 65 |
University of California, Los Angeles
| 3 years |
| Thirumalai M. Ravi | M | - |
University of California, Los Angeles
| 7 years |
| Michael J. Shearer | M | - |
University of California, Los Angeles
| 6 years |
| Andrew Evan Shapiro | M | 63 |
University of California, Los Angeles
| 4 years |
| Eric Chu | M | - |
University of California, Los Angeles
| 5 years |
| Shawn C. Boyd | M | - |
University of California, Los Angeles
| 2 years |
| West David Whittaker | M | - |
University of California, Los Angeles
| 2 years |
| Rudy S. Hobson | M | - |
University of California, Los Angeles
| 2 years |
| Saba Hekmat | M | - |
University of California, Los Angeles
| 5 years |
| Brian T. Brugman | M | - |
University of California, Los Angeles
| 5 years |
| Andy Hwang | M | - |
University of California, Los Angeles
| 3 years |
| James Kim | M | - |
University of California, Los Angeles
| 2 years |
| Min-Soo Kim | M | - |
University of California, Los Angeles
| 4 years |
| Ren He | M | - |
University of California, Los Angeles
| 3 years |
| Mark Heller | M | - |
University of California, Los Angeles
| 2 years |
| Murray McQueen | M | - |
University of California, Los Angeles
| 2 years |
| Chris Thornberg | M | - |
University of California, Los Angeles
| 6 years |
| Nathan Weissman | M | - |
University of California, Los Angeles
| 4 years |
| Craig Barton Burger | M | - |
University of California, Los Angeles
| 2 years |
| Elizabeth A. McFarland | F | - |
University of California, Los Angeles
| 4 years |
| Linda Havard | F | 68 |
University of California, Los Angeles
| 2 years |
| Katherine Herrick Drake | F | - |
University of California, Los Angeles
| 2 years |
| Scott E. Young | M | 62 |
University of California, Los Angeles
| 2 years |
| Sanjay Sabnani | M | 52 |
University of California, Los Angeles
| 4 years |
| Natalie Monarch Baumgartner | M | - |
University of California, Los Angeles
| 1 years |
| Mark W. Holmlund | M | - |
University of California, Los Angeles
| 2 years |
| Victor Sze | M | 57 |
University of California, Los Angeles
| 5 years |
| Javier I. Escobar | M | 55 |
University of California, Los Angeles
| 4 years |
| John W. Langley | M | - |
University of California, Los Angeles
| 2 years |
| Brent Jensen | M | 54 |
University of California, Los Angeles
| 5 years |
| Dawn M. Cica | F | - |
University of California, Los Angeles
| 3 years |
| Todd Gross | M | - |
University of California, Los Angeles
| 3 years |
| Loran F. Graham | M | - |
University of California, Los Angeles
| 4 years |
| Daniel P. Garcia | M | - |
University of California, Los Angeles
| 1 years |
| Paul I. Terasaki | M | - |
University of California, Los Angeles
| 3 years |
| Larry W. Edelman | M | - |
University of California, Los Angeles
| 12 years |
| Leanne Karns | F | - |
University of California, Los Angeles
| 2 years |
| Wayne Levin | M | 61 |
University of California, Los Angeles
| 4 years |
| Sally M. Abel | F | - |
University of California, Los Angeles
| 3 years |
| Peter Tan Keh Yan | M | 75 |
University of California, Los Angeles
| 2 years |
| Raymond Barrios | M | - |
University of California, Los Angeles
| 4 years |
| Ron Hirson | M | - |
University of California, Los Angeles
| 4 years |
| Kevin Cunningham | M | 54 |
University of California, Los Angeles
| 4 years |
| Augustin Araya | M | - |
University of California, Los Angeles
| 4 years |
| Xingping Charles Yang | M | 62 |
University of California, Los Angeles
| 1 years |
| Bruce D. Seder | M | - |
University of California, Los Angeles
| 4 years |
| Adam Zachary Epstein | M | - |
University of California, Los Angeles
| 2 years |
| Aaron Kessler | M | - |
University of California, Los Angeles
| 4 years |
| Matt Balaker | M | - |
University of California, Los Angeles
| 4 years |
| Ping Huang | M | - |
University of California, Los Angeles
| 2 years |
| Andy Hargreaves | M | - |
University of California, Los Angeles
| 4 years |
| David Chen | M | - |
University of California, Los Angeles
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 91 | 91.00% |
| Canada | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephan R. Targan
- Personal Network
